TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
CGEN

Compugen

Healthcare · Biotechnology

2.30$ -1.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Compugen (CGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 138 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGEN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
68 121 114 110 124 115 115 107 98 157 146 138
60 115 106 102 115 106 107 98 89 148 137 129
48 14 69 12 7.2 18 15 6.5 7.5 91 12 10
58 51 101 92 113 103 104 94 86 146 135 125
2.8 61 4.3 9.8 2.1 0.3 3.1 3.8 2.8 0.3 2.3 4.1
-2.8 – -4.3 – – – – – – – – –
14 56 54 52 63 60 58 56 54 54 51 50
10 26 25 25 28 20 21 21 20 23 22 23
0.6 0.6 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.6
9.8 3.5 13 2.4 11 1.8 11 1.8 9.1 2.4 2.5 2.2
53 66 60 58 60 55 57 50 44 103 95 89
– -475 – -484 – -489 – -503 – -453 – -468
88 88 90 90 90 90 92 94 94 95 95 95

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?